Tamoxifen-loaded novel liposomal formulations: evaluation of anticancer activity on DMBA-TPA induced mouse skin carcinogenesis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of drug targeting (Print)

• Publication date

  2012-05-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/1061186X.2012.694887PMID 22643315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Uterine Sarcomas - a review].

  2012cited by this paper
• Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.

  2012cited by this paper
• Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin

  2011cited by this paper
• Transcutol containing vesicles for topical delivery of minoxidil

  2011cited by this paper
• Elastic liposomes for topical and transdermal drug delivery.

  2010cited by this paper
• Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.

  2010cited by this paper
• Positron emission tomography imaging of DMBA/TPA mouse skin multi‐step tumorigenesis

  2010influential reference
• Therapeutic Potential of New 4-hydroxy-tamoxifen-Loaded pH-gradient Liposomes in a Multiple Myeloma Experimental Model

  2010cited by this paper
• Uterine sarcomas: a review.

  2010cited by this paper
• Evaluation of ovotoxicity induced by 7, 12-dimethylbenz[a]anthracene and its 3,4-diol metabolite utilizing a rat in vitro ovarian culture system.

  2009cited by this paper
• Studies on tamoxifen encapsulated in lipid vesicles: Effect on the growth of human breast cancer MCF-7 cells

  2009cited by this paper
• Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.

  2009influential reference
• The rationale and potential of cancer chemoprevention with special emphasis on breast cancer.

  2009cited by this paper
• Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line.

  2009cited by this paper
• Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: the 'personalised' approach?

  2009cited by this paper
• Vesicular carriers for dermal drug delivery

  2009cited by this paper
• Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole.

  2008cited by this paper
• Drug-Induced Ocular Disorders

  2008cited by this paper
• Liposomes for (trans)dermal delivery of tretinoin: influence of drug concentration and vesicle composition

  2008cited by this paper
• Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance.

  2008cited by this paper
• Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.

  2007cited by this paper
• Inhibitory effects of asiatic acid on 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice.

  2007cited by this paper
• Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.

  2007cited by this paper
• Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction

  2007cited by this paper
• New frontiers in intravesical therapies and drug delivery.

  2006cited by this paper
• Comparison of uterine malignancies that develop during and following tamoxifen therapy.

  2006cited by this paper
• Chemoprevention: a primary cancer prevention strategy.

  2005cited by this paper
• Elastic vesicles as topical/transdermal drug delivery systems

  2005cited by this paper
• Modulation of apoptosis by cancer chemopreventive agents.

  2005cited by this paper
• Should Tamoxifen Be Used in Breast Cancer Prevention?

  2004cited by this paper
• Deformable liposomes for dermal administration of methotrexate.

  2004cited by this paper
• Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.

  2004influential reference
• Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes.

  2004cited by this paper
• The Selective Estrogen Receptor Modulator 4‐Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines

  2003cited by this paper
• Structure of the skin barrier and its modulation by vesicular formulations.

  2003cited by this paper
• Comparative Potencies of Nutraceuticals in Chemically Induced Skin Tumor Prevention

  2002cited by this paper
• A review of selective estrogen receptor modulators in the treatment of breast and endometrial cancer.

  2002cited by this paper
• Chemoprevention of human skin cancer.

  2002cited by this paper
• The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators.

  2002cited by this paper
• Carboxymethyl benzylamide dextran and tamoxifen combination inhibits tumor growth and angiogenesis.

  2001cited by this paper
• Interaction of liposome formulations with human skin in vitro.

  2001cited by this paper
• Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.

  1998cited by this paper
• Changes in gap junctional intercellular communication in mouse skin carcinogenesis.

  1997cited by this paper
• Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.

  1997cited by this paper
• Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.

  1990cited by this paper
• Sci Pharm www.scipharm.at Research article Open Access Tamoxifen Citrate Encapsulated Sustained Release Liposomes: Preparation and Evaluation of Physicochemical Properties

  year unknowncited by this paper

• QbD-Anchored Preparation and Assessment of Transethosomal Gel for Enhanced Skin Permeation of Tamoxifen Citrate.

  2025cites this paper
• An insight of various vesicular systems, erythrosomes, and exosomes to control metastasis and cancer

  2023cites this paper
• Interaction of Neutral and Protonated Tamoxifen with the DPPC Lipid Bilayer using Molecular Dynamics Simulation.

  2023cites this paper
• CHEMOPREVENTIVE AGENTS ON A MOUSE SKIN CARCINOGENESIS MODEL: AN INTEGRATIVE REVIEW

  2022cites this paper
• Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption.

  2021cites this paper
• Hybrid nanomaterials-based biomedical phototheranostic platforms

  2021cites this paper
• PREDICTION OF ANTICANCER ACTIVITY OF POTENTIAL ANTICANCER COMPOUNDS USING PASS ONLINE SOFTWARE

  2020cites this paper
• Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation

  2020cites this paper
• Genetic dissection of clonal lineage relationships with hydroxytamoxifen liposomes

  2018cites this paper
• Topical and Transdermal Nanomedicines for Cancer Therapy

  2018cites this paper
• APPLICATION OF RESPONSE SURFACE METHODOLOGY IN OPTIMIZATION OF PACLITAXEL LIPOSOMES PREPARED BY THIN FILM HYDRATION TECHNIQUE

  2018cites this paper
• PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors

  2017cites this paper
• INVESTIGATION OF EFFECT OF PHOSPHOLIPIDS ON PHYSICAL AND FUNCTIONAL CHARACTERIZATION OF PACLITAXEL LIPOSOMES

  2017cites this paper
• Dermatokinetics as an Important Tool to Assess the Bioavailability of Drugs by Topical Nanocarriers.

  2017cites this paper
• Liposomal fusidic acid as a potential delivery system: a new paradigm in the treatment of chronic plaque psoriasis

  2016cites this paper
• Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'.

  2016cites this paper
• Chemically induced skin carcinogenesis: Updates in experimental models (Review)

  2016cites this paper
• Targeted nano-delivery of novel omega-3 conjugate against hepatocellular carcinoma: Regulating COX-2/bcl-2 expression in an animal model.

  2016cites this paper
• Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development.

  2016cites this paper
• Chemopreventive efficacy of menthol on carcinogen-induced cutaneous carcinoma through inhibition of inflammation and oxidative stress in mice.

  2015cites this paper
• Novel phospholipid-based topical formulations of tamoxifen: evaluation for antipsoriatic activity using mouse-tail model

  2014cites this paper
• Chemomodulatory efficacy of lycopene on antioxidant enzymes and carcinogen-induced cutaneum carcinoma in mice.

  2014cites this paper
• Topical Delivery of Aceclofenac: Challenges and Promises of Novel Drug Delivery Systems

  2014cites this paper
• Transdermal flux predictions for selected selective oestrogen receptor modulators (SERMs): comparison with experimental results.

  2013cites this paper
• Carbon nanotubes for delivery of small molecule drugs.

  2013cites this paper